In Vivo Brain Dialysis Study of the Somatodendritic Release of Serotonin in the Raphe Nuclei of the Rat: Effects of 8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin

Abstract: The characteristics of the serotonin (5‐HT) output in the dorsal and median raphe nuclei of the rat were studied using in vivo microdialysis. The basal output of 5‐HT increased after KC1 was added to the perfusion fluid. In contrast, neither the omission of calcium ions nor the addition of 0.5 nM tetrodotoxin affected dialysate 5‐HT or 5‐hy‐droxyindoleacetic acid (5‐H1AA). Reserpine did not decrease the output of 5‐HT and 5‐HIAA 24 h later and p‐chloroamphetamine increased 5‐HT in both vehicle‐ and reserpine‐treated rats severalfold. 8‐Hydroxy‐2‐(di‐n‐pro‐pylamino)tetralin (8‐OH‐DPAT), at 1 or 10 μM, perfused into the raphe did not change the outputs of 5‐HT or 5‐HIAA. Higher doses (0.1, Land 10 mM) increased extracellular 5‐HT in the raphe, probably via an inhibition of uptake. In animals bearing two probes (raphe nuclei and ventral hippocampus), only the 10 vaM dose of 8‐OH‐DPAT perfused into the raphe decreased the hippocampal output of 5‐HT and 5‐HIAA. The systemic injection of 0.1 mg/kg 8‐OH‐DPAT decreased dialysate 5‐HT and 5‐HIAA in the raphe and hippocampus. These results suggest that extracellular 5‐HT in raphe nuclei originates from a cytoplasmic pool and is not dependent on either nerve impulse of 5‐HT neurons or local activation of 5‐HT1A receptors.

[1]  G. Damsma,et al.  Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  J. Bockaert,et al.  Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  H. Schoemaker,et al.  [3H]8-OH-DPAT labels the serotonin transporter in the rat striatum. , 1986, European journal of pharmacology.

[4]  W. Wolf,et al.  The 5-HT transporter is an additional site of action for the 5-HT agonists RU 24969 and TFMPP , 1991, Neurochemistry International.

[5]  E. Azmitia The Serotonin-Producing Neurons of the Midbrain Median and Dorsal Raphe Nuclei , 1978 .

[6]  C. de Montigny,et al.  Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain , 1987, Synapse.

[7]  G. Aghajanian,et al.  Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices , 1983, Brain Research.

[8]  M. Hamon,et al.  Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. , 1985, European journal of pharmacology.

[9]  S. Haj-Dahmane,et al.  K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: Anin vitro electrophysiological study , 1991, Neuroscience.

[10]  J. Long,et al.  Regional differences in the response of serotonergic neurons in rat CNS to drugs. , 1983, European journal of pharmacology.

[11]  S. Hjorth,et al.  The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[12]  B. Cox,et al.  Pharmacological evidence for the existence of two distinct serotonin receptors in rat brain , 1982, Neuropharmacology.

[13]  S. Hjorth,et al.  Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor , 1990, Journal of Neuroscience Methods.

[14]  S. Hjorth,et al.  Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. , 1991, Life sciences.

[15]  U. Ungerstedt,et al.  Influence of a carrier transport process on in vivo release and metabolism of dopamine: dependence on extracellular Na+. , 1989, Life sciences.

[16]  F. Artigas,et al.  Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. , 1992, European journal of pharmacology.

[17]  P. Kalivas,et al.  A Comparison of Axonal and Somatodendritic Dopamine Release Using In Vivo Dialysis , 1991, Journal of neurochemistry.

[18]  N. Akaike,et al.  Blockade of the voltage-dependent sodium current in isolated rat hippocampal neurons by tetrodotoxin and lidocaine , 1989, Brain Research.

[19]  H. Yamamura,et al.  Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.

[20]  T. Jessell,et al.  Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.

[21]  G. Flemström Intracellular accumulation and permeability effects of some weak acids in the isolated frog gastric mucosa. , 1971, Acta physiologica Scandinavica.

[22]  P. Hutson,et al.  An in vivo dialysis and behavioural study of the release of 5‐HT by p‐chloroamphetamine in reserpine‐treated rats , 1989, British journal of pharmacology.

[23]  U. Ungerstedt Stereotaxic mapping of the monoamine pathways in the rat brain. , 1971, Acta physiologica Scandinavica. Supplementum.

[24]  P. H. Hutson,et al.  Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis , 1989, Neuroscience Letters.

[25]  B. Westerink,et al.  Characterization and Pharmacological Responsiveness of Dopamine Release Recorded by Microdialysis in the Substantia Nigra of Conscious Rats , 1991, Journal of neurochemistry.

[26]  J. Ieni,et al.  The 5-HT1A receptor probe [3H]8-OH-DPAT labels the 5-HT transporter in human platelets. , 1988, Life sciences.

[27]  Roberto Invernizzi,et al.  Administration of 8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin in Raphe Nuclei Dorsalis and Medianus Reduces Serotonin Synthesis in the Rat Brain: Differences in Potency and Regional Sensitivity , 1991, Journal of neurochemistry.

[28]  G. Aghajanian,et al.  Noradrenergic innervation of serotonergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography , 1981, Brain Research.

[29]  A. Sleight,et al.  In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism , 1990, Neuroscience.

[30]  P. A. Shore,et al.  Reserpine: Basic and Clinical Pharmacology , 1978 .

[31]  Y. Okuma,et al.  KCl-induced calcium-independent release of endogenous dopamine from rat brain slices , 1986, Brain Research.

[32]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[33]  G. Aghajanian,et al.  (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. , 1986, European journal of pharmacology.

[34]  F. Artigas,et al.  Simultaneous Effects of p‐Chloroamphetamine, d‐Fenfluramine, and Reserpine on Free and Stored 5‐Hydroxytryptamine in Brain and Blood , 1992, Journal of neurochemistry.

[35]  Roberto Invernizzi,et al.  Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex , 1992, Brain Research.

[36]  U. Trendelenburg The TiPS lecture: functional aspects of the neuronal uptake of noradrenaline. , 1991, Trends in pharmacological sciences.

[37]  H. Kremer,et al.  The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease , 1991, Neuroscience Letters.

[38]  F. Hery,et al.  The role of serotonin release and autoreceptors in the dorsalis raphe nucleus in the control of serotonin release in the cat caudate nucleus , 1990, Neuroscience.

[39]  G. Chiara,et al.  Serotonin release estimated by transcortical dialysis in freely-moving rats , 1989, Neuroscience.

[40]  F. Hery,et al.  Release of Serotonin in Structures Containing Serotoninergic Nerve Cell Bodies: Dorsalis Raphe Nucleus and Nodose Ganglia of the Cat a , 1986, Annals of the New York Academy of Sciences.

[41]  D G Grahame-Smith,et al.  In Vivo Measurement of Extracellular 5‐Hydroxytryptamine in Hippocampus of the Anaesthetized Rat Using Microdialysis: Changes in Relation to 5‐Hydroxytryptaminergic Neuronal Activity , 1989, Journal of neurochemistry.

[42]  Gilles Bonvento,et al.  Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain , 1992, Neuroscience Letters.

[43]  C. Sotelo,et al.  Direct Immunohistochemical Evidence of the Existence of 5‐HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei , 1990, The European journal of neuroscience.

[44]  Lars Olson,et al.  Ascending Monoamine Neurons to the Telencephalon and Diencephalon , 1966 .

[45]  A. Björklund,et al.  Endogenous Release of Neuronal Serotonin and 5‐Hydroxyindoleacetic Acid in the Caudate‐Putamen of the Rat as Revealed by Intracerebral Dialysis Coupled to High‐Performance Liquid Chromatography with Fluorimetric Detection , 1988, Journal of neurochemistry.

[46]  J. Pujol,et al.  Evidence for the localization of 5HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain , 1985, Neurochemistry International.

[47]  M. Raiteri,et al.  Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings , 1982, Neurochemistry International.

[48]  J. Glowinski,et al.  Release of dopamine in vivo from cat substantia nigra , 1977, Nature.

[49]  F. Artaud,et al.  Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. , 1984, European journal of pharmacology.

[50]  A. Beaudet,et al.  The serotonin neurons in nucleus raphe dorsalis of adult rat: A light and electron microscope radioautographic study , 1982, The Journal of comparative neurology.

[51]  H. Ralston,et al.  Serotonin‐containing structures in the nucleus raphe dorsalis of the cat: An ultrastructural analysis of dendrites, presynaptic dendrites, and axon terminals , 1987, The Journal of comparative neurology.

[52]  D G Grahame-Smith,et al.  5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis , 1989, British journal of pharmacology.

[53]  C. Montigny,et al.  Electrophysiologically-identified serotonin receptors in the rat CNS Effect of antidepressant treatment , 1984, Neuropharmacology.

[54]  J. Glowinski,et al.  Dendritic release of dopamine in the substantia nigra , 1981, Nature.

[55]  F. Hery,et al.  In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat , 1982, Brain Research Bulletin.

[56]  C. Sinton,et al.  Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. , 1988, European journal of pharmacology.

[57]  G. Aghajanian,et al.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists , 1987, Synapse.

[58]  M. Piercey,et al.  Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleus. , 1988, European journal of pharmacology.

[59]  R. Summers,et al.  Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. , 1990, The Journal of pharmacology and experimental therapeutics.

[60]  Michael J. Minzenberg,et al.  Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release , 1989, Brain Research.

[61]  F Benfenati,et al.  Quantitative autoradiographic localization of [3H]imipramine binding sites in the brain of the rat: relationship to ascending 5-hydroxytryptamine neuron systems. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Autoradiographic localization of [3H]paroxetine specific binding in the rat brain , 1990, Neurochemistry International.

[63]  A. Carlsson,et al.  Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra , 1985, The Journal of pharmacy and pharmacology.

[64]  F. Artigas,et al.  Regional Distribution of Extracellular 5‐Hydroxytryptamine and 5‐Hydroxyindoleacetic Acid in the Brain of Freely Moving Rats , 1991, Journal of neurochemistry.

[65]  C. P. Vandermaelen,et al.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. , 1986, European journal of pharmacology.